Du er på: newsweb.no
newsweb.no
Utsteder
Utst.ID
Instrument
Kategori
Fra dato
Til dato
Velg marked
Vis kun aktive utstedere Info...
  Nullstill...
MeldingsID: 436346
Dato/tid 12.10.2017 16:41
Utsteder Weifa ASA
UtstederID WEIFA
Instrument
Marked OB
Kategori ANNEN INFORMASJONSPLIKTIG REGULATORISK INFORMASJON
Informasjonspliktig   Informasjonspliktige opplysninger   Lagringspliktig melding
Vedlegg
Tittel Compulsory acquisition - approval of guarantee
Tekst
Oslo Børs, in capacity as take-over supervisory authority, 
has approved payment guarantee pursuant to the Securities 
Trading Act section 6-22 3rd sub-section no. 3 in connection 
with compulsory acquisition ("squeeze-out") of shares in 
Weifa ASA without preceding mandatory offer. In this 
respect, Oslo Børs has also considered the other relevant 
conditions applicable for the exemption to present a 
mandatory offer pursuant to the Securities Trading Act 
section 6-22 3rd sub-section.

Karo Pharma AB has resolved to effect compulsory acquisition 
of the shares in Weifa ASA not already held by Karo Pharma 
AB pursuant to the Public Limited Liability Companies Act 
section 4-25.

The price offered under the compulsory acquisition is NOK 35 
per share, which would have been the minimum offer price for 
a mandatory offer from Karo Pharma AB to the shareholders of 
Weifa ASA.

Attached is a copy of the guarantee document issued by 
Swedbank AB, a company organized and existing under the laws 
of Sweden acting through its Norwegian branch Swedbank 
Norge, for the benefit of those that are subject to the 
compulsory acquisition. The guarantee document includes, 
amongst others, information on, the deadline for presenting 
claims under the guarantee, the address for delivery of 
claims and the documentation that must be submitted.

Les om ansvar og rettigheter.